NovAccess Global Inc. (OTCMKTS:XSNX) Sees Significant Decline in Short Interest

NovAccess Global Inc. (OTCMKTS:XSNX) saw a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 400 shares, a drop of 97.7% from the October 15th total of 17,300 shares. Based on an average trading volume of 7,000 shares, the short-interest ratio is currently 0.1 days.

NovAccess Global Stock Performance

XSNX opened at $0.01 on Wednesday. The stock’s 50 day simple moving average is $0.01 and its 200 day simple moving average is $0.01. NovAccess Global has a 1-year low of $0.00 and a 1-year high of $0.05.

NovAccess Global Company Profile

NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient’s immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.